A randomized controlled trial of the cost-utility of second-generation antipsychotics in people with psychosis and eligible for clozapine

Linda Davies, Thomas R E Barnes, Peter B. Jones, Shôn Lewis, Fiona Gaughran, Karen Hayhurst, Alison Markwick, Helen Lloyd

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'A randomized controlled trial of the cost-utility of second-generation antipsychotics in people with psychosis and eligible for clozapine'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology